Real-World Outcomes Favor Standard Care in HER2-Positive Metastatic Breast Cancer
(MedPage Today) -- At the San Antonio Breast Cancer Symposium (SABCS), a large retrospective analysis of U.S. electronic health records compared outcomes for patients with HER2-positive metastatic breast cancer who received first-line guideline...